share_log

Healthcare Realty Trust Analyst Ratings

Healthcare Realty Trust Analyst Ratings

医疗保健房地产信托分析师评级
Benzinga ·  2023/10/06 08:46
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/06/2023 13.18% BMO Capital $20 → $17 Maintains Market Perform
10/03/2023 13.18% Wedbush → $17 Initiates Coverage On → Outperform
08/22/2023 13.18% Citigroup $19 → $17 Maintains Neutral
08/11/2023 59.79% Barclays $25 → $24 Maintains Equal-Weight
05/11/2023 66.44% Barclays $24 → $25 Maintains Overweight
04/19/2023 — Wells Fargo Initiates Coverage On → Equal-Weight
03/29/2023 59.79% Barclays $28 → $24 Maintains Overweight
03/06/2023 33.16% Credit Suisse $23 → $20 Downgrades Outperform → Neutral
12/14/2022 33.16% Citigroup $22.5 → $20 Downgrades Buy → Neutral
12/02/2022 46.47% JP Morgan $28 → $22 Maintains Neutral
09/19/2022 86.42% Citigroup $27 → $28 Upgrades Neutral → Buy
08/11/2022 99.73% SMBC Nikko → $30 Upgrades Neutral → Outperform
07/18/2022 93.08% Credit Suisse $34 → $29 Maintains Outperform
05/10/2022 113.05% Berenberg $35 → $32 Downgrades Buy → Hold
04/26/2022 119.71% Barclays → $33 Initiates Coverage On → Overweight
02/01/2022 — Credit Suisse Initiates Coverage On → Outperform
01/07/2022 126.36% BMO Capital → $34 Downgrades Outperform → Market Perform
08/20/2021 — Raymond James Downgrades Strong Buy → Market Perform
07/29/2021 119.71% Morgan Stanley $31 → $33 Maintains Equal-Weight
03/31/2021 106.39% Wells Fargo $29 → $31 Maintains Equal-Weight
03/15/2021 106.39% Morgan Stanley $30 → $31 Maintains Equal-Weight
01/28/2021 113.05% ScotiaBank → $32 Initiates Coverage On → Sector Perform
01/13/2021 119.71% Jefferies $30 → $33 Upgrades Hold → Buy
09/18/2020 119.71% Capital One → $33 Upgrades Equal-Weight → Overweight
09/02/2020 113.05% Stifel → $32 Reinstates → Buy
08/31/2020 133.02% Raymond James $34 → $35 Upgrades Outperform → Strong Buy
04/29/2020 126.36% Raymond James $38 → $34 Maintains Outperform
04/07/2020 93.08% Citigroup $38 → $29 Downgrades Buy → Neutral
04/03/2020 73.1% Wells Fargo $33 → $26 Maintains Equal-Weight
04/03/2020 99.73% JP Morgan $35 → $30 Maintains Neutral
03/26/2020 66.44% Morgan Stanley $33 → $25 Maintains Equal-Weight
03/12/2020 153% Raymond James $36 → $38 Maintains Outperform
03/09/2020 186.28% BMO Capital $35 → $43 Upgrades Market Perform → Outperform
12/20/2019 126.36% Mizuho → $34 Assumes → Neutral
12/12/2019 — Citigroup Upgrades Neutral → Buy
11/26/2019 133.02% Stifel $33 → $35 Upgrades Hold → Buy
09/17/2019 119.71% Morgan Stanley $31 → $33 Maintains Equal-Weight
06/20/2019 126.36% Citigroup → $34 Initiates Coverage On → Neutral
01/08/2019 — Raymond James Upgrades Underperform → Market Perform
11/13/2018 113.05% Mizuho → $32 Upgrades Neutral → Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
10/06/2023 13.18% 蒙特利尔银行资本 $20→$17 维护 市场表现
10/03/2023 13.18% 韦德布什 →$17 开始承保 →跑赢大盘
2023年08月22日 13.18% 花旗集团 $19→$17 维护 中性
2023年08月11日 59.79% 巴克莱 $25→$24 维护 等重
2023年05月11日 66.44% 巴克莱 $24→$25 维护 超重
04/19/2023 - 富国银行 开始承保 →等重
03/29/2023 59.79% 巴克莱 $28→$24 维护 超重
03/06/2023 33.16% 瑞士信贷 $23→$20 评级下调 跑赢→中性
2022年12月14日 33.16% 花旗集团 $22.5→$20 评级下调 购买→中性
12/02/2022 46.47% 摩根大通 $28→$22 维护 中性
2022/09/19 86.42% 花旗集团 $27→$28 升级 中性→购买
2022年08月11日 99.73% SMBC日兴 →$30 升级 中性→表现优异
07/18/2022 93.08% 瑞士信贷 $34→$29 维护 跑赢大盘
2022年05月10日 113.05% 贝伦伯格 $35→$32 评级下调 购买→Hold
04/26/2022 119.71% 巴克莱 →$33 开始承保 →超重
02/01/2022 - 瑞士信贷 开始承保 →跑赢大盘
01/07/2022 126.36% 蒙特利尔银行资本 →$34 评级下调 跑赢→市场表现
08/20/2021 - 雷蒙德·詹姆斯 评级下调 强劲的购买→市场表现
07/29/2021 119.71% 摩根士丹利 $31→$33 维护 等重
03/31/2021 106.39% 富国银行 $29→$31 维护 等重
03/15/2021 106.39% 摩根士丹利 $30→$31 维护 等重
2021年1月28日 113.05% 加拿大丰业银行 →$32 开始承保 →行业表现
2021/01/13 119.71% 杰富瑞 $30→$33 升级 持有→购买
09/18/2020 119.71% 大写一 →$33 升级 等重→超重
09/02/2020 113.05% Stifel →$32 恢复 →购买
08/31/2020 133.02% 雷蒙德·詹姆斯 $34→$35 升级 跑赢→强势买入
04/29/2020 126.36% 雷蒙德·詹姆斯 $38→$34 维护 跑赢大盘
04/07/2020 93.08% 花旗集团 $38→$29 评级下调 购买→中性
04/03/2020 73.1% 富国银行 $33→$26 维护 等重
04/03/2020 99.73% 摩根大通 $35→$30 维护 中性
03/26/2020 66.44% 摩根士丹利 $33→$25 维护 等重
03/12/2020 153% 雷蒙德·詹姆斯 $36→$38 维护 跑赢大盘
03/09/2020 186.28% 蒙特利尔银行资本 $35→$43 升级 市场表现优于→
2019年12月20日 126.36% 瑞穗 →$34 假设 →中性
2019年12月12日 - 花旗集团 升级 中性→购买
2019年11月26日 133.02% Stifel $33→$35 升级 持有→购买
2019/09/17 119.71% 摩根士丹利 $31→$33 维护 等重
2019年06月20日 126.36% 花旗集团 →$34 开始承保 →中性
2019年08月01日 - 雷蒙德·詹姆斯 升级 表现逊于→市场表现
2018年11月13日 113.05% 瑞穗 →$32 升级 中性→购买

What is the target price for Healthcare Realty Trust (HR)?

医疗房地产信托基金(HR)的目标价格是多少？

The latest price target for Healthcare Realty Trust (NYSE: HR) was reported by BMO Capital on October 6, 2023. The analyst firm set a price target for $17.00 expecting HR to rise to within 12 months (a possible 13.18% upside). 10 analyst firms have reported ratings in the last year.

BMO Capital于2023年10月6日报告了Healthcare Realty Trust(纽约证券交易所代码：HR)的最新目标价。这家分析公司将目标价定为17.00美元，预计人力资源将在12个月内上涨(可能上涨13.18%)。去年有10家分析公司公布了评级。

What is the most recent analyst rating for Healthcare Realty Trust (HR)?

Healthcare Realty Trust(HR)的最新分析师评级是多少？

The latest analyst rating for Healthcare Realty Trust (NYSE: HR) was provided by BMO Capital, and Healthcare Realty Trust maintained their market perform rating.

对Healthcare Realty Trust(纽约证券交易所代码：HR)的最新分析师评级由BMO Capital提供，Healthcare Realty Trust维持其市场表现评级。

When is the next analyst rating going to be posted or updated for Healthcare Realty Trust (HR)?

Healthcare Realty Trust(HR)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.

分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与Healthcare Realty Trust的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。医疗房地产信托基金的上一次评级是在2023年10月6日提交的，所以你应该预计下一次评级将在2024年10月6日左右的某个时候公布。

Is the Analyst Rating Healthcare Realty Trust (HR) correct?

分析师对Healthcare Realty Trust(HR)的评级正确吗？

While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a maintained with a price target of $20.00 to $17.00. The current price Healthcare Realty Trust (HR) is trading at is $15.02, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的医疗房地产信托(HR)评级维持不变，目标价在20.00美元至17.00美元之间。Healthcare Realty Trust(HR)目前的交易价格为15.02美元，超出了分析师的预测范围。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发